The use of immunotherapy to enhance tumor rejection immunity in leukemic (L2C) guinea pigs following remission induction with MeCCNU.
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage; D001853:Bone Marrow / Q000276:immunology / Q000528:radiation effects; D002464:Cell Migration Inhibition; D005260:Female; D006084:Graft Rejection; D006168:Guinea Pigs; D007109:Immunity; D007167:Immunotherapy; D007942:Leukemia, Experimental / Q000276:immunology* / Q000628:therapy; D008264:Macrophages / Q000276:immunology; D009368:Neoplasm Transplantation; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D011425:Propionibacterium acnes; D012673:Semustine / Q000627:therapeutic use*
D001500:BCG Vaccine; D009607:Nitrosourea Compounds; D012673:Semustine